About this role
Summary A leading international pharmaceutical group is seeking a Head of Mergers & Acquisitions to drive its inorganic growth strategy across Europe and selected international markets. This is a high-impact leadership role focused on identifying, evaluating and executing acquisitions, strategic partnerships, joint ventures and product portfolio transactions across the pharmaceutical and healthcare sectors. The successful candidate will play a key role in expanding the organisation's footprint, supporting both the core generics business and wider healthcare interests. The ideal candidate will bring a proven track record of end-to-end M&A execution within the pharmaceutical industry, with particular preference given to candidates from generics or off-patent medicine environments. Whilst sector experience is important, the ability to successfully originate, negotiate, execute and integrate transactions is considered the most critical success factor. Responsibilities - Develop and execute the organisation's M&A and corporate development strategy in line with global growth objectives. - Identify, evaluate and prioritise acquisition, licensing, joint venture and strategic partnership opportunities. - Lead end-to-end transaction processes including target identification, valuation, due diligence, negotiation, execution and integration. - Assess opportunities involving companies, product portfolios, brands and marketing authorisations. - Build and maintain financial models, business cases and investment recommendations for executive leadership. - Lead cross-functional deal teams involving finance, legal, regulatory, commercial and operational stakeholders. - Manage relationships with external advisers, investment banks, consultants and transaction counterparties. - Support expansion into existing and new European markets through inorganic growth initiatives. - Evaluate opportunities across both the core pharmaceutical business and wid...